Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients - News Press Release | PharmiWeb.com

Links shared publicly online about this topic.

  • 1,112
    total visits

Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients - News Press Release | PharmiWeb.com

pharmiweb.com —

- One-Year Phase II Data Presented at the 2010 ACTRIMS MeetingPR NewswirePARIS, June 5, 2010PARIS, June 5, 2010 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) reported today new one-year data from a Phase II study with teriflunomide, a

View full resource at pharmiweb.com

Tags: Multiple Sclerosis, Sanofi-Aventis

  • Share

Most Recently Shared on June 7, 2010 at 12:53 pm By:

MS_Wisdom2 OrganizedWisdom MS

Press Release: PARIS, June 5, 2010 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) reported today new... http://bit.ly/apPTtX

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

US_HealthCareOW US_HealthCareOW

Advertisement